(LARS) Score Validation of Turkish Language

Ankara University222 enrolled

Overview

Long-term bowel dysfunction after resection for rectal cancer, known as low anterior resection syndrome (LARS), is observed in many patients. The LARS score was developed to measure this syndrome and its impact on quality of life in Danish patients. Recently, English and many other language versions have been validated. The aim of this study was to validate the Turkish translation of the LARS score in Turkish patients who have undergone treatment for rectal cancer.

A total of 326 patients were reviewed and contacted for the study, and 222 (68%) were eligible for the analyses. The association between the LARS score and quality of life and the test-retest reliability were studied. The intraclass correlation coefficient (ICC) was calculated to understand the degree of reliability.

Study Type

OBSERVATIONAL

Enrollment

222

Conditions

LARS - Low Anterior Resection Syndrome

Interventions

Rectal Resection PatientsPROCEDURE

Patients who have had low anterior resection of rectum was categorized for their quality of life related to surgery

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria:The inclusion criteria were * rectal adenocarcinoma within 15 cm from the anal verge * LAR with either PME or TME. * Bowel continuity restored for at least 18 months when invited for the study. Exclusion Criteria:Exclusion criteria included * failed R0 surgery, * recurrence or dissemination, * having intestinal stoma, * previous cancer (except minor skin cancers) * dementia and inability to speak Turkish (i.e., the need for a translator during treatment).

Outcomes

Primary Outcomes

Validity of LARS Score

The translated questionaire was validated on Turkish speaking patients

Time frame: From Feb 2016 to Feb 2020

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.